English

NEXELL THERAPEUTICS INC

EDGAR

Quarterly report (10-Q) · filed 2002-11-14

31 filing records in this dataset, filed from 1996-06-12 to 2002-11-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2002-09-30 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-1.21 million USD

2002-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -4816000 USD Source
Operating Cash Flow: -3604000 USD Source

Free cash flow

-1.21 million USD

2002-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -4816000 USD Source
Operating Cash Flow: -3604000 USD Source
Capital Expenditure: 23000 USD Source
Capital Expenditure: 23000 USD Source

Cash and cash equivalents: 2.97 million USD 2002-09-30 Source
Exact value

2970000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

3.19 million USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Revenue: 13180000 USD · 2001-01-01 – 2001-12-31 Source
Revenue: 13030000 USD · 2001-01-01 – 2001-09-30 Source
Revenue: 3040000 USD · 2002-01-01 – 2002-03-31 Source
Revenue: 0 USD · 2002-04-01 – 2002-06-30 Source
Revenue: 0 USD · 2002-07-01 – 2002-09-30 Source

Net income

-37.5 million USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Net income: -23310000 USD · 2001-01-01 – 2001-12-31 Source
Net income: -20308000 USD · 2001-01-01 – 2001-09-30 Source
Net income: 1176000 USD · 2002-01-01 – 2002-03-31 Source
Net income: -34970000 USD · 2002-04-01 – 2002-06-30 Source
Net income: -661000 USD · 2002-07-01 – 2002-09-30 Source

Operating cash flow

-7.49 million USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Operating cash flow: -10597000 USD · 2001-01-01 – 2001-12-31 Source
Operating cash flow: -7921000 USD · 2001-01-01 – 2001-09-30 Source
Operating cash flow: -1061000 USD · 2002-01-01 – 2002-03-31 Source
Operating cash flow: -3604000 USD · 2002-01-01 – 2002-06-30 Source
Operating cash flow: -1061000 USD · 2002-01-01 – 2002-03-31 Source
Operating cash flow: -4816000 USD · 2002-01-01 – 2002-09-30 Source
Operating cash flow: -3604000 USD · 2002-01-01 – 2002-06-30 Source

Capital expenditure

74 thousand USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Capital expenditure: 635000 USD · 2001-01-01 – 2001-12-31 Source
Capital expenditure: 584000 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 0 USD · 2002-01-01 – 2002-03-31 Source
Capital expenditure: 23000 USD · 2002-01-01 – 2002-06-30 Source
Capital expenditure: 0 USD · 2002-01-01 – 2002-03-31 Source
Capital expenditure: 23000 USD · 2002-01-01 – 2002-09-30 Source
Capital expenditure: 23000 USD · 2002-01-01 – 2002-06-30 Source

Free cash flow

-7.57 million USD

2001-10-01 – 2002-09-30

Exact inputs and evidence

Operating cash flow: -10597000 USD · 2001-01-01 – 2001-12-31 Source
Operating cash flow: -7921000 USD · 2001-01-01 – 2001-09-30 Source
Operating cash flow: -1061000 USD · 2002-01-01 – 2002-03-31 Source
Operating cash flow: -3604000 USD · 2002-01-01 – 2002-06-30 Source
Operating cash flow: -1061000 USD · 2002-01-01 – 2002-03-31 Source
Operating cash flow: -4816000 USD · 2002-01-01 – 2002-09-30 Source
Operating cash flow: -3604000 USD · 2002-01-01 – 2002-06-30 Source
Capital expenditure: 635000 USD · 2001-01-01 – 2001-12-31 Source
Capital expenditure: 584000 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 0 USD · 2002-01-01 – 2002-03-31 Source
Capital expenditure: 23000 USD · 2002-01-01 – 2002-06-30 Source
Capital expenditure: 0 USD · 2002-01-01 – 2002-03-31 Source
Capital expenditure: 23000 USD · 2002-01-01 – 2002-09-30 Source
Capital expenditure: 23000 USD · 2002-01-01 – 2002-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2002-11-14.

Financial data available through: 2001-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2001-12-31
Operating income: 7 of 11 periods available· newest 2001-12-31
Net income: 8 of 11 periods available· newest 2001-12-31
Operating cash flow: 8 of 11 periods available· newest 2001-12-31
Capital expenditure: 8 of 11 periods available· newest 2001-12-31
Total assets: 7 of 11 periods available· newest 2001-12-31
Total liabilities: 7 of 11 periods available· newest 2001-12-31
Current assets: 7 of 11 periods available· newest 2001-12-31
Current liabilities: 7 of 11 periods available· newest 2001-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2001-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-27.5%

Prior period

USD 18.18 million

2000-01-01 – 2000-12-31
Current period

USD 13.18 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

13180000 − 18180000 = -5000000 USD

18180000 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
13180000 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · NEXELL THERAPEUTICS INC · 2001-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Year-over-year change in Revenue: -5000000 USD Concept: fundies:Revenue Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 13180000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-02-000599.txt#3367 Input fundies:Revenue: 18180000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-02-000599.txt#3367
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 4.79 million

Prior period

−USD 28.1 million

2000-01-01 – 2000-12-31
Current period

−USD 23.31 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

-23310000 − -28095000 = 4785000 USD

-28095000 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
-23310000 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · NEXELL THERAPEUTICS INC · 2001-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Year-over-year change in Net income: 4785000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -23310000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-02-000599.txt#3584 Input fundies:NetIncome: -28095000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-02-000599.txt#3584
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 13.48 million

Prior period

−USD 24.08 million

2000-01-01 – 2000-12-31
Current period

−USD 10.6 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

-10597000 − -24077000 = 13480000 USD

-24077000 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
-10597000 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · NEXELL THERAPEUTICS INC · 2001-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Year-over-year change in Operating cash flow: 13480000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -10597000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-02-000599.txt#3603 Input fundies:OperatingCashFlow: -24077000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-02-000599.txt#3603
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-38.9%

Prior period

USD 1.04 million

2000-01-01 – 2000-12-31
Current period

USD 635,000

2001-01-01 – 2001-12-31

Exact inputs and evidence

635000 − 1040000 = -405000 USD

1040000 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
635000 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · NEXELL THERAPEUTICS INC · 2001-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Year-over-year change in Capital expenditure: -405000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 635000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-02-000599.txt#3607 Input fundies:CapitalExpenditure: 1040000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-02-000599.txt#3607
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2001 2001-01-01 – 2001-12-31

Revenue USD 13.18 million 100% of revenue
Cost of revenue USD 6.81 million 52% of revenue
Operating expenses USD 29.61 million 225% of revenue
Operating income −USD 23.25 million −176% of revenue
Tax, interest and other Derived USD 63,000 0.5% of revenue
Net income −USD 23.31 million −177% of revenue

Cash

Operating cash flow −USD 10.6 million −80% of revenue
Capital expenditure USD 635,000 4.8% of revenue
Free cash flow Derived −USD 11.23 million −85% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1995 Not shown: operating income or net income is not reported.
1996 Not shown: operating income or net income is not reported.
1997 Operating loss: operating costs were 1,333% of revenue.
1998 Operating loss: operating costs were 392% of revenue.
1999 Operating loss: operating costs were 337% of revenue.
2000 Operating loss: operating costs were 279% of revenue.
2001 Operating loss: operating costs were 276% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1995 1995-01-01 – 1995-12-31	0	5112000 Derived	-5112000	128000 Derived	-5240000	-4135000 Derived	Source 1995-01-01 – 1995-12-31: 0 USD Inspect Revenue Open source 1995-01-01 – 1995-12-31: -5112000 USD Inspect Operating Income Open source 1995-01-01 – 1995-12-31: -5240000 USD Inspect Net Income Open source 1995-01-01 – 1995-12-31: -4085000 USD Inspect Operating Cash Flow Open source 1995-01-01 – 1995-12-31: 50000 USD Inspect Capital Expenditure Open source
1996 1996-01-01 – 1996-12-31	0	21734000 Derived	-21734000	-1874000 Derived	-19860000	-5969000 Derived	Source 1996-01-01 – 1996-12-31: 0 USD Inspect Revenue Open source 1996-01-01 – 1996-12-31: -21734000 USD Inspect Operating Income Open source 1996-01-01 – 1996-12-31: -19860000 USD Inspect Net Income Open source 1996-01-01 – 1996-12-31: -5167000 USD Inspect Operating Cash Flow Open source 1996-01-01 – 1996-12-31: 802000 USD Inspect Capital Expenditure Open source
1997 1997-01-01 – 1997-12-31	5002000	66687000 Derived	-61685000	-5486000 Derived	-56199000	-17742000 Derived	Source 1997-01-01 – 1997-12-31: 5002000 USD Inspect Revenue Open source 1997-01-01 – 1997-12-31: -61685000 USD Inspect Operating Income Open source 1997-01-01 – 1997-12-31: -56199000 USD Inspect Net Income Open source 1997-01-01 – 1997-12-31: -17059000 USD Inspect Operating Cash Flow Open source 1997-01-01 – 1997-12-31: 683000 USD Inspect Capital Expenditure Open source
1998 1998-01-01 – 1998-12-31	13443000	52666000 Derived	-39223000	-4260000 Derived	-34963000	-24391000 Derived	Source 1998-01-01 – 1998-12-31: 13443000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -39223000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -34963000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -23263000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 1128000 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	14961000	50429000 Derived	-35468000	205000 Derived	-35673000	-31174000 Derived	Source 1999-01-01 – 1999-12-31: 14961000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -35468000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -35673000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -27851000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 3323000 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	18180000	50672000 Derived	-32492000	-4397000 Derived	-28095000	-25117000 Derived	Source 2000-01-01 – 2000-12-31: 18180000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -32492000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -28095000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -24077000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 1040000 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	13180000	36427000 Derived	-23247000	63000 Derived	-23310000	-11232000 Derived	Source 2001-01-01 – 2001-12-31: 13180000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -23247000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -23310000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -10597000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 635000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 13.2M 2001

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Revenue	0	Revenue: 0 Open source
19961996-12-31	Revenue	0	Revenue: 0 Open source
19971997-12-31	Revenue	5002000	Revenue: 5002000 Open source
19981998-12-31	Revenue	13443000	Revenue: 13443000 Open source
19991999-12-31	Revenue	14961000	Revenue: 14961000 Open source
20002000-12-31	Revenue	18180000	Revenue: 18180000 Open source
20012001-12-31	Revenue	13180000	Revenue: 13180000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-27.5% 2001

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
19961996-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
19971997-12-31	Year over year	No prior comparable period	Revenue: 5002000 Open source Revenue: 0 Open source
19981998-12-31	Year over year	168.8%	Revenue: 13443000 Open source Revenue: 5002000 Open source
19991999-12-31	Year over year	11.3%	Revenue: 14961000 Open source Revenue: 13443000 Open source
20002000-12-31	Year over year	21.5%	Revenue: 18180000 Open source Revenue: 14961000 Open source
20012001-12-31	Year over year	-27.5%	Revenue: 13180000 Open source Revenue: 18180000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -176.4% 2001

Net margin -176.9% 2001

Free cash flow margin -85.2% 2001

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Operating margin	Not reported	Operating Income: -5112000 Open source Revenue: 0 Open source
19961996-12-31	Operating margin	Not reported	Operating Income: -21734000 Open source Revenue: 0 Open source
19971997-12-31	Operating margin	-1,233.2%	Operating Income: -61685000 Open source Revenue: 5002000 Open source
19981998-12-31	Operating margin	-291.8%	Operating Income: -39223000 Open source Revenue: 13443000 Open source
19991999-12-31	Operating margin	-237.1%	Operating Income: -35468000 Open source Revenue: 14961000 Open source
20002000-12-31	Operating margin	-178.7%	Operating Income: -32492000 Open source Revenue: 18180000 Open source
20012001-12-31	Operating margin	-176.4%	Operating Income: -23247000 Open source Revenue: 13180000 Open source
19951995-12-31	Net margin	Not reported	Net Income: -5240000 Open source Revenue: 0 Open source
19961996-12-31	Net margin	Not reported	Net Income: -19860000 Open source Revenue: 0 Open source
19971997-12-31	Net margin	-1,123.5%	Net Income: -56199000 Open source Revenue: 5002000 Open source
19981998-12-31	Net margin	-260.1%	Net Income: -34963000 Open source Revenue: 13443000 Open source
19991999-12-31	Net margin	-238.4%	Net Income: -35673000 Open source Revenue: 14961000 Open source
20002000-12-31	Net margin	-154.5%	Net Income: -28095000 Open source Revenue: 18180000 Open source
20012001-12-31	Net margin	-176.9%	Net Income: -23310000 Open source Revenue: 13180000 Open source
19951995-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -4085000 Open source Capital Expenditure: 50000 Open source
19961996-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -5167000 Open source Capital Expenditure: 802000 Open source
19971997-12-31	Free cash flow margin	-354.7%	Revenue: 5002000 Open source Operating Cash Flow: -17059000 Open source Capital Expenditure: 683000 Open source
19981998-12-31	Free cash flow margin	-181.4%	Revenue: 13443000 Open source Operating Cash Flow: -23263000 Open source Capital Expenditure: 1128000 Open source
19991999-12-31	Free cash flow margin	-208.4%	Revenue: 14961000 Open source Operating Cash Flow: -27851000 Open source Capital Expenditure: 3323000 Open source
20002000-12-31	Free cash flow margin	-138.2%	Revenue: 18180000 Open source Operating Cash Flow: -24077000 Open source Capital Expenditure: 1040000 Open source
20012001-12-31	Free cash flow margin	-85.2%	Revenue: 13180000 Open source Operating Cash Flow: -10597000 Open source Capital Expenditure: 635000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -10.6M 2001

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Operating cash flow	-4085000	Operating Cash Flow: -4085000 Open source
19961996-12-31	Operating cash flow	-5167000	Operating Cash Flow: -5167000 Open source
19971997-12-31	Operating cash flow	-17059000	Operating Cash Flow: -17059000 Open source
19981998-12-31	Operating cash flow	-23263000	Operating Cash Flow: -23263000 Open source
19991999-12-31	Operating cash flow	-27851000	Operating Cash Flow: -27851000 Open source
20002000-12-31	Operating cash flow	-24077000	Operating Cash Flow: -24077000 Open source
20012001-12-31	Operating cash flow	-10597000	Operating Cash Flow: -10597000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -11.2M 2001

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19951995-12-31	Free cash flow	-4135000	Operating Cash Flow: -4085000 Open source Capital Expenditure: 50000 Open source
19961996-12-31	Free cash flow	-5969000	Operating Cash Flow: -5167000 Open source Capital Expenditure: 802000 Open source
19971997-12-31	Free cash flow	-17742000	Operating Cash Flow: -17059000 Open source Capital Expenditure: 683000 Open source
19981998-12-31	Free cash flow	-24391000	Operating Cash Flow: -23263000 Open source Capital Expenditure: 1128000 Open source
19991999-12-31	Free cash flow	-31174000	Operating Cash Flow: -27851000 Open source Capital Expenditure: 3323000 Open source
20002000-12-31	Free cash flow	-25117000	Operating Cash Flow: -24077000 Open source Capital Expenditure: 1040000 Open source
20012001-12-31	Free cash flow	-11232000	Operating Cash Flow: -10597000 Open source Capital Expenditure: 635000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

14.1% 2001

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Liabilities / assets	91.2%	Total Liabilities: 2698000 Open source Total Assets: 2958000 Open source
19961996-12-31	Liabilities / assets	6%	Total Liabilities: 3101000 Open source Total Assets: 51692000 Open source
19971997-12-31	Liabilities / assets	28.1%	Total Liabilities: 34239000 Open source Total Assets: 121947000 Open source
19981998-12-31	Liabilities / assets	45.4%	Total Liabilities: 40529000 Open source Total Assets: 89344000 Open source
19991999-12-31	Liabilities / assets	11.3%	Total Liabilities: 10625000 Open source Total Assets: 93839000 Open source
20002000-12-31	Liabilities / assets	18.6%	Total Liabilities: 14015000 Open source Total Assets: 75455000 Open source
20012001-12-31	Liabilities / assets	14.1%	Total Liabilities: 6264000 Open source Total Assets: 44514000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.78× 2001

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
19951995-12-31	Current assets / current liabilities	1.18×	Current Assets: 2625000 Open source Current Liabilities: 2234000 Open source
19961996-12-31	Current assets / current liabilities	19.6×	Current Assets: 47259000 Open source Current Liabilities: 2411000 Open source
19971997-12-31	Current assets / current liabilities	16.89×	Current Assets: 65214000 Open source Current Liabilities: 3860000 Open source
19981998-12-31	Current assets / current liabilities	4.77×	Current Assets: 40515000 Open source Current Liabilities: 8498000 Open source
19991999-12-31	Current assets / current liabilities	3.71×	Current Assets: 39456000 Open source Current Liabilities: 10625000 Open source
20002000-12-31	Current assets / current liabilities	2.6×	Current Assets: 27419000 Open source Current Liabilities: 10528000 Open source
20012001-12-31	Current assets / current liabilities	1.78×	Current Assets: 9152000 Open source Current Liabilities: 5139000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1994-01-01 – 1994-12-31	−USD 3.61 million Exact value Exact value: -3609000 USD 1994-01-01 – 1994-12-31: -3609000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEXELL THERAPEUTICS INC · 1994-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Net Income: -3609000 USD Concept: fundies:NetIncome Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3ANetIncome&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3609000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0000864009-97-000008.txt#2257 The citation records this snapshot. The page link may show a newer release later.	−USD 3.11 million Exact value Exact value: -3110000 USD 1994-01-01 – 1994-12-31: -3110000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEXELL THERAPEUTICS INC · 1994-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Operating Cash Flow: -3110000 USD Concept: fundies:OperatingCashFlow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3AOperatingCashFlow&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3110000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0000864009-97-000008.txt#2284 The citation records this snapshot. The page link may show a newer release later.	USD 71,000 Exact value Exact value: 71000 USD 1994-01-01 – 1994-12-31: 71000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEXELL THERAPEUTICS INC · 1994-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Capital Expenditure: 71000 USD Concept: fundies:CapitalExpenditure Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3ACapitalExpenditure&period=1994-12-31&surface=latest&period_type=duration&start=1994-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 71000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0000864009-97-000008.txt#2291 The citation records this snapshot. The page link may show a newer release later.	−USD 3.18 million Calculation and evidence -3110000 − 71000 USD Exact free cash flow: -3181000 USD 1994-01-01 – 1994-12-31: -3110000 USD · Inspect Operating Cash Flow · Source 1994-01-01 – 1994-12-31: 71000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEXELL THERAPEUTICS INC · 1994-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Free cash flow: -3181000 USD Concept: free-cash-flow Period: 1994-01-01 to 1994-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3110000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0000864009-97-000008.txt#2284 Input fundies:CapitalExpenditure: 71000 USD (1994-01-01 to 1994-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0000864009-97-000008.txt#2291 The citation records this snapshot. The page link may show a newer release later.
1995 1995-01-01 – 1995-12-31	−USD 5.24 million Exact value Exact value: -5240000 USD 1995-01-01 – 1995-12-31: -5240000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEXELL THERAPEUTICS INC · 1995-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Net Income: -5240000 USD Concept: fundies:NetIncome Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3ANetIncome&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5240000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001036050-98-000514.txt#2501 The citation records this snapshot. The page link may show a newer release later.	−USD 4.09 million Exact value Exact value: -4085000 USD 1995-01-01 – 1995-12-31: -4085000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEXELL THERAPEUTICS INC · 1995-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Operating Cash Flow: -4085000 USD Concept: fundies:OperatingCashFlow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3AOperatingCashFlow&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4085000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001036050-98-000514.txt#2523 The citation records this snapshot. The page link may show a newer release later.	USD 50,000 Exact value Exact value: 50000 USD 1995-01-01 – 1995-12-31: 50000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEXELL THERAPEUTICS INC · 1995-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Capital Expenditure: 50000 USD Concept: fundies:CapitalExpenditure Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3ACapitalExpenditure&period=1995-12-31&surface=latest&period_type=duration&start=1995-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 50000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001036050-98-000514.txt#2529 The citation records this snapshot. The page link may show a newer release later.	−USD 4.14 million Calculation and evidence -4085000 − 50000 USD Exact free cash flow: -4135000 USD 1995-01-01 – 1995-12-31: -4085000 USD · Inspect Operating Cash Flow · Source 1995-01-01 – 1995-12-31: 50000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEXELL THERAPEUTICS INC · 1995-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Free cash flow: -4135000 USD Concept: free-cash-flow Period: 1995-01-01 to 1995-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4085000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001036050-98-000514.txt#2523 Input fundies:CapitalExpenditure: 50000 USD (1995-01-01 to 1995-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001036050-98-000514.txt#2529 The citation records this snapshot. The page link may show a newer release later.
1996 1996-01-01 – 1996-12-31	−USD 19.86 million Exact value Exact value: -19860000 USD 1996-01-01 – 1996-12-31: -19860000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEXELL THERAPEUTICS INC · 1996-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Net Income: -19860000 USD Concept: fundies:NetIncome Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3ANetIncome&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:NetIncome: -19860000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001036050-98-000514.txt#2501 The citation records this snapshot. The page link may show a newer release later.	−USD 5.17 million Exact value Exact value: -5167000 USD 1996-01-01 – 1996-12-31: -5167000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEXELL THERAPEUTICS INC · 1996-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Operating Cash Flow: -5167000 USD Concept: fundies:OperatingCashFlow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3AOperatingCashFlow&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5167000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001036050-98-000514.txt#2523 The citation records this snapshot. The page link may show a newer release later.	USD 802,000 Exact value Exact value: 802000 USD 1996-01-01 – 1996-12-31: 802000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEXELL THERAPEUTICS INC · 1996-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Capital Expenditure: 802000 USD Concept: fundies:CapitalExpenditure Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3ACapitalExpenditure&period=1996-12-31&surface=latest&period_type=duration&start=1996-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 802000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001036050-98-000514.txt#2529 The citation records this snapshot. The page link may show a newer release later.	−USD 5.97 million Calculation and evidence -5167000 − 802000 USD Exact free cash flow: -5969000 USD 1996-01-01 – 1996-12-31: -5167000 USD · Inspect Operating Cash Flow · Source 1996-01-01 – 1996-12-31: 802000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEXELL THERAPEUTICS INC · 1996-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Free cash flow: -5969000 USD Concept: free-cash-flow Period: 1996-01-01 to 1996-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5167000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001036050-98-000514.txt#2523 Input fundies:CapitalExpenditure: 802000 USD (1996-01-01 to 1996-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001036050-98-000514.txt#2529 The citation records this snapshot. The page link may show a newer release later.
1997 1997-01-01 – 1997-12-31	−USD 56.2 million Exact value Exact value: -56199000 USD 1997-01-01 – 1997-12-31: -56199000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEXELL THERAPEUTICS INC · 1997-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Net Income: -56199000 USD Concept: fundies:NetIncome Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3ANetIncome&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:NetIncome: -56199000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0000898430-00-001062.txt#2434 The citation records this snapshot. The page link may show a newer release later.	−USD 17.06 million Exact value Exact value: -17059000 USD 1997-01-01 – 1997-12-31: -17059000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEXELL THERAPEUTICS INC · 1997-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Operating Cash Flow: -17059000 USD Concept: fundies:OperatingCashFlow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3AOperatingCashFlow&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -17059000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0000898430-00-001062.txt#2452 The citation records this snapshot. The page link may show a newer release later.	USD 683,000 Exact value Exact value: 683000 USD 1997-01-01 – 1997-12-31: 683000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEXELL THERAPEUTICS INC · 1997-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Capital Expenditure: 683000 USD Concept: fundies:CapitalExpenditure Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3ACapitalExpenditure&period=1997-12-31&surface=latest&period_type=duration&start=1997-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 683000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0000898430-00-001062.txt#2458 The citation records this snapshot. The page link may show a newer release later.	−USD 17.74 million Calculation and evidence -17059000 − 683000 USD Exact free cash flow: -17742000 USD 1997-01-01 – 1997-12-31: -17059000 USD · Inspect Operating Cash Flow · Source 1997-01-01 – 1997-12-31: 683000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEXELL THERAPEUTICS INC · 1997-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Free cash flow: -17742000 USD Concept: free-cash-flow Period: 1997-01-01 to 1997-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -17059000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0000898430-00-001062.txt#2452 Input fundies:CapitalExpenditure: 683000 USD (1997-01-01 to 1997-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0000898430-00-001062.txt#2458 The citation records this snapshot. The page link may show a newer release later.
1998 1998-01-01 – 1998-12-31	−USD 34.96 million Exact value Exact value: -34963000 USD 1998-01-01 – 1998-12-31: -34963000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEXELL THERAPEUTICS INC · 1998-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Net Income: -34963000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -34963000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-01-000693.txt#3012 The citation records this snapshot. The page link may show a newer release later.	−USD 23.26 million Exact value Exact value: -23263000 USD 1998-01-01 – 1998-12-31: -23263000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEXELL THERAPEUTICS INC · 1998-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Operating Cash Flow: -23263000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -23263000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-01-000693.txt#3033 The citation records this snapshot. The page link may show a newer release later.	USD 1.13 million Exact value Exact value: 1128000 USD 1998-01-01 – 1998-12-31: 1128000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEXELL THERAPEUTICS INC · 1998-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Capital Expenditure: 1128000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1128000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-01-000693.txt#3037 The citation records this snapshot. The page link may show a newer release later.	−USD 24.39 million Calculation and evidence -23263000 − 1128000 USD Exact free cash flow: -24391000 USD 1998-01-01 – 1998-12-31: -23263000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 1128000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEXELL THERAPEUTICS INC · 1998-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Free cash flow: -24391000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -23263000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-01-000693.txt#3033 Input fundies:CapitalExpenditure: 1128000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-01-000693.txt#3037 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 35.67 million Exact value Exact value: -35673000 USD 1999-01-01 – 1999-12-31: -35673000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEXELL THERAPEUTICS INC · 1999-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Net Income: -35673000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -35673000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-02-000599.txt#3584 The citation records this snapshot. The page link may show a newer release later.	−USD 27.85 million Exact value Exact value: -27851000 USD 1999-01-01 – 1999-12-31: -27851000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEXELL THERAPEUTICS INC · 1999-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Operating Cash Flow: -27851000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -27851000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-02-000599.txt#3603 The citation records this snapshot. The page link may show a newer release later.	USD 3.32 million Exact value Exact value: 3323000 USD 1999-01-01 – 1999-12-31: 3323000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEXELL THERAPEUTICS INC · 1999-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Capital Expenditure: 3323000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3323000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-02-000599.txt#3607 The citation records this snapshot. The page link may show a newer release later.	−USD 31.17 million Calculation and evidence -27851000 − 3323000 USD Exact free cash flow: -31174000 USD 1999-01-01 – 1999-12-31: -27851000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 3323000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEXELL THERAPEUTICS INC · 1999-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Free cash flow: -31174000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -27851000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-02-000599.txt#3603 Input fundies:CapitalExpenditure: 3323000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-02-000599.txt#3607 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 28.1 million Exact value Exact value: -28095000 USD 2000-01-01 – 2000-12-31: -28095000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEXELL THERAPEUTICS INC · 2000-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Net Income: -28095000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -28095000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-02-000599.txt#3584 The citation records this snapshot. The page link may show a newer release later.	−USD 24.08 million Exact value Exact value: -24077000 USD 2000-01-01 – 2000-12-31: -24077000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEXELL THERAPEUTICS INC · 2000-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Operating Cash Flow: -24077000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -24077000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-02-000599.txt#3603 The citation records this snapshot. The page link may show a newer release later.	USD 1.04 million Exact value Exact value: 1040000 USD 2000-01-01 – 2000-12-31: 1040000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEXELL THERAPEUTICS INC · 2000-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Capital Expenditure: 1040000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1040000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-02-000599.txt#3607 The citation records this snapshot. The page link may show a newer release later.	−USD 25.12 million Calculation and evidence -24077000 − 1040000 USD Exact free cash flow: -25117000 USD 2000-01-01 – 2000-12-31: -24077000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 1040000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEXELL THERAPEUTICS INC · 2000-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Free cash flow: -25117000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -24077000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-02-000599.txt#3603 Input fundies:CapitalExpenditure: 1040000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-02-000599.txt#3607 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 23.31 million Exact value Exact value: -23310000 USD 2001-01-01 – 2001-12-31: -23310000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NEXELL THERAPEUTICS INC · 2001-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Net Income: -23310000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23310000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-02-000599.txt#3584 The citation records this snapshot. The page link may show a newer release later.	−USD 10.6 million Exact value Exact value: -10597000 USD 2001-01-01 – 2001-12-31: -10597000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NEXELL THERAPEUTICS INC · 2001-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Operating Cash Flow: -10597000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10597000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-02-000599.txt#3603 The citation records this snapshot. The page link may show a newer release later.	USD 635,000 Exact value Exact value: 635000 USD 2001-01-01 – 2001-12-31: 635000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NEXELL THERAPEUTICS INC · 2001-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Capital Expenditure: 635000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 635000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-02-000599.txt#3607 The citation records this snapshot. The page link may show a newer release later.	−USD 11.23 million Calculation and evidence -10597000 − 635000 USD Exact free cash flow: -11232000 USD 2001-01-01 – 2001-12-31: -10597000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 635000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NEXELL THERAPEUTICS INC · 2001-12-31 NEXELL THERAPEUTICS INC (edgar:864009) Free cash flow: -11232000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/864009?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10597000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-02-000599.txt#3603 Input fundies:CapitalExpenditure: 635000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/864009/0001017062-02-000599.txt#3607 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

31 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000864009, 864009, edgar:864009

Also known as VIMRX PHARMACEUTICALS INC

NEXELL THERAPEUTICS INC

Latest quarter

Revenue

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2001 2001-01-01 – 2001-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation